Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis.

Author: BighelliIrene, CerasoAnna, ChalkouKonstantina, CiprianiAndrea, DavisJohn M, DörriesCarola, FurukawaToshi A, HuhnMaximilian, LeuchtStefan, SalantiGeorgia, Schneider-ThomaJohannes, SiafisSpyridon

Paper Details 
Original Abstract of the Article :
Schizophrenia is a common, severe, and usually chronic disorder. Maintenance treatment with antipsychotic drugs can prevent relapse but also causes side-effects. We aimed to compare the efficacy and tolerability of antipsychotics as maintenance treatment for non-treatment resistant patients with sch...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/S0140-6736(21)01997-8

データ提供:米国国立医学図書館(NLM)

Antipsychotics in Schizophrenia: A Comprehensive Assessment of Efficacy and Tolerability

The desert of mental health research is constantly evolving, seeking better ways to manage complex conditions. This research delves into the world of antipsychotics, specifically their efficacy and tolerability in managing schizophrenia. The researchers conducted a comprehensive systematic review and network meta-analysis of 32 different oral and long-acting injectable antipsychotics. This extensive study provides a valuable roadmap for clinicians to make informed decisions about the best antipsychotic treatment for individuals with schizophrenia, considering both efficacy and side effects.

A Guide Through the Desert: Navigating Antipsychotic Treatment for Schizophrenia

This research offers a comprehensive guide to antipsychotic treatment for schizophrenia. The findings provide valuable insight into the efficacy and tolerability of various antipsychotic medications, enabling clinicians to make more informed decisions about treatment options for individual patients.

A Guiding Light: Antipsychotics and the Management of Schizophrenia

For those struggling with the challenging landscape of schizophrenia, finding the right treatment is like discovering a vital oasis. This research provides a valuable guide for clinicians and patients, illuminating the best possible antipsychotic treatment options for individuals with schizophrenia.

Dr. Camel's Conclusion

This study demonstrates the power of comprehensive research in understanding the complexities of mental health. Just as a camel navigates the vast desert landscape, we need to continue exploring the best ways to treat mental disorders, ensuring that those facing these challenges find the support and resources they need.

Date :
  1. Date Completed 2022-04-04
  2. Date Revised 2022-09-30
Further Info :

Pubmed ID

35219395

DOI: Digital Object Identifier

10.1016/S0140-6736(21)01997-8

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.